Biological E gets DCGI nod for Covid-19 vaccine in children aged 12 to 18 years
Corbevax is a receptor-binding domain (RBD) protein sub-unit Covid-19 vaccine and is India’s first indigenously developed Covid-19 vaccine
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Feb 22
Corbevax is a receptor-binding domain (RBD) protein sub-unit Covid-19 vaccine and is India’s first indigenously developed Covid-19 vaccine
21 Feb 22
In the interim analysis, Dupixent showed positive results in reducing itch and hives (primary endpoints) but did not…
21 Feb 22
The Freezor and Freezor Xtra catheters are flexible, single-use devices that freeze the cardiac tissue and block redundant…
18 Feb 22
The recall applies to powder formulas, including Similac, Alimentum and EleCare, but does not include any metabolic deficiency…
18 Feb 22
The US agency has accepted the company’s supplemental Biologics License Application (sBLA) for the drug to expand its…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Feb 22
The announcement builds on Moderna’s recent plans to expand in the Asia-Pacific region and will establish a local…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Feb 22
Curve’s drug discovery platform will support the identification and optimisation of novel small molecule drug candidates against MSD…
16 Feb 22
ImmunoGen will receive $13m in upfront payment for initial targets and is eligible to receive an additional $32.5m…
16 Feb 22
The company will establish new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong, to scale up its mRNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Feb 22
The agreement follows the US government’s initial deal for 700,000 doses of Evusheld, which are already being administered…